Citations

Clear

29 citation(s) found for "Merlo, M".

NAV3 is a genetic determinant of myocardial recovery in dilated cardiomyopathy and attenuates cardiac fibrosis
Wang, M, Liu, D, Nguyen, T. T. , McNamara, Dennis M. , Barlera, Simona, Merlo, M, Krejci, J, Kilianova, A, Groote, P De, Weishilboum, R, Pereira, Naveen L. , Pileggi, Silvana , Mestroni, Luisa , Merlo, Marco , Sinagra, Gianfranco , Pinet, F , Groote, Pascal de

Mayo Clinic

European Heart Journal | October 15, 2022 | Volume: 43 | Issue: Supplement_2 | Pages: No page available

10.1093/eurheartj/ehac544.2990 Get It

Abstract Background A genome-wide association study (GWAS) assessing change in left ventricular ejection fraction (LVEF) in dilated cardiomyopathy (DCM), a surrogate marker of morbidity and mortality in heart failure (HF), had not been performed previously and could provide insight into novel biological pathways that could lead to the development of new drugs that might target myocardial recovery. The presence and extent of cardiac fibrosis in DCM is independently associated with myocardial recovery and cardiovascular mortality. Purpose To identify the biological relevance of genetic targets that are associated with change in LVEF in patients with DCM. Methods A GWAS was performed using DNA from 686 patients with recent onset DCM who were on standard HF therapy using change in LVEF at a median of 6 months after initial diagnosis. Cultured human cardiac fibroblasts (HCFs) were used as an in vitro model to study the functional and biological relevance of the gene target identified in the GWAS. Specifically, HCFs were transfected with siRNA by using the Lipofectamine™ RNAiMAX Transfection Reagent for gene knockdown (KD). RNA-seq was performed using the Illumina TruSeq protocol with expression analysis conducted with the EdgeR package. Ingenuity Pathway Analysis was used. Results A single-nucleotide polymorphism, rs11105445(G>A), mapping to the neuron navigator 3 (NAV3) gene (rs11105445, p=2.37E-07; beta 2.74±0.53) was associated with improvement in LVEF. We performed a phenome-wide association study using data from the UK Biobank and demonstrated that genetic variation in NAV3 was significantly associated with HF mortality (p=3.2E-28), highlighting the potential importance of this gene in HF. Using GTEx data we demonstrated that in LV tissue the minor allele A was associated with ↓NAV3 expression (p=0.03) suggesting that ↓NAV3 expression might be associated with improvement in LVEF. We demonstrated that NAV3 KD significantly ↓TGF-β1 mediated HCF transdifferentiation into myofibroblasts, ↓α-smooth muscle actin (ACTA2) and ↓collagen I (COL1A1), therefore NAV3 KD was anti-fibrotic (see Figure 1), 1a. HCFs treated by vehicle/TGF-β1 after KD of NAV3/ctrl, and ACTA2 and COL1A1 were analyzed by qPCR; 1b. Representative immunofluorescence staining for α-SMA (in green), RNA-seq after NAV3 KD followed by pathway analysis suggested that NAV3 exerted its effect by regulating cell cycle related proteins (Figure 2), 2a. Volcano plot shows significant differentially expressed genes identified by RNA-seq analysis (down-regulated in blue, up-regulated in red); 2b. NAV3 KD significantly increased expression of cell cycle related proteins, which was validated by Western blot. Conclusions Decreased expression of NAV3 is associated with myocardial recovery in DCM, most likely due to its anti-fibrotic effect via direct regulation of cell cycle proteins. The role of NAV3 as a novel therapeutic target in DCM needs to be explored. Funding Acknowledgement Type of funding sources: Public Institution(s). Main funding source(s): Mayo Clinic Center for Individualized MedicineMayo Clinic Department of Cardiovascular Medicine
Acute myocarditis associated with desmosomal gene variants
Raimondi, F, Olivotto, Iacopo, Peretto, G, Merlo, M, Camici, P G, Ammirati, Enrico , Piriou, Nicolas , Mohiddin, Saidi , Imazio, Massimo , Aquaro, Giovanni Donato , Olivotto, Iacopo , Heyning, Caroline M. Van De , Merlo, M, Klaassen, Sabine , Poller, Wolfgang , Adler, Eric D , Cooper, Leslie T.

Mayo Clinic

European Heart Journal | October 15, 2022 | Volume: 43 | Issue: Supplement_2 | Pages: No page available

10.1093/eurheartj/ehac544.1682 Get It

Abstract Background The risk of adverse cardiovascular events in patients with acute myocarditis (AM) and desmosomal gene variants (DGV) remains unknown. Purpose To ascertain the risk of death, ventricular arrhythmias, recurrent myocarditis, and heart failure (main endpoint) in patients with AM and pathogenic or likely pathogenetic DGV. Methods In a retrospective international study from 23 hospitals, 97 patients were included: 36 with AM and DGV (DGV(+)), 25 with AM and negative gene testing (DGV(−)), and 36 AM patients without genetics (w/o genetics). All patients had troponin elevation plus findings consistent with AM on histology or at cardiac magnetic resonance imaging (CMRI). In 86 patients CMRI changes in function and structure were re-assessed at follow-up. Results In the DGV(+) AM group (88.9% DSP variants), median age was 24 years, 91.7% presented with chest pain, and median left ventricular (LV) ejection fraction was 56% on CMRI (p=NS vs. the other 2 groups). Kaplan-Meier curves demonstrated a higher risk of the main endpoint in DGV(+) AM compared to DGV(−) and w/o genetics patients (62.3% vs. 17.5% vs. 5.3% at 5 years respectively; p<0.0001), driven by myocarditis recurrence and ventricular arrhythmias (Figure 1A, B). At follow-up CMRI, a higher number of late-gadolinium enhanced segments was found in DGV(+) AM. Conclusions Patients with AM and evidence of DGV have a higher incidence of adverse cardiovascular events compared with AM patients without DGV. Further prospective studies are needed to ascertain if genetic testing might improve risk stratification of patients with AM who are considered at low risk. Funding Acknowledgement Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Italian Ministry of Health
Prognostic role of myocardial inflammation in patients with undefined left ventricular arrhythmogenic cardiomyopathy
Peretto, G, Merlo, M, Benedetti, S, Cappelletto, C, Casari, G, Sala, S, Sinagra, G, Bella, P Della, Casella, Michela , Merlo, M, Cappelletto, C, Rizzo, Stefania , Russo, A Dello, Basso, Cristina , Sinagra, G, Cooper, Leslie T.

Mayo Clinic

EP Europace | May 19, 2022 | Volume: 24 | Issue: Supplement_1 | Pages: No page available

10.1093/europace/euac053.545 Get It

Abstract Funding Acknowledgements Type of funding sources: None. Background Etiology identification and risk stratification represent major issues for patients presenting with undefined left ventricular arrhythmogenic cardiomyopathy (ULVACM). Purpose To investigate the role of genetics and histology for ULVACM classification, management, and risk assessment. Methods We retrospectively analyzed a multicenter cohort of patients (screened n=1037) with ULVACM defined by ventricular arrhythmia (VA) onset, nonischemic late gadolinium enhancement (LGE) limited to the LV, and no severe dilated cardiomyopathy (LVEF≥40%). We selected patients undergoing both next generation sequencing (NGS) screening and endomyocardial biopsy (EMB) for etiology definition. When feasible, immunosuppressive therapy (IST) was used to target active myocardial inflammation (AMI). The study endpoint was a composite of cardiac death, heart transplantation and malignant VAs (VT, VF, appropriate ICD treatment). Results The study cohort is composed by 135 ULVACM patients (age 43±14 years, 63% males, LVEF 55±7 %). NGS identified pathogenic or likely-pathogenic variants (PVs/LPVs) consistent with ACM in 21 cases (16%), whereas EMB showed AMI in 78 patients (58%), including 13/21 PVs/LPVs+ (62%). After reclassification of 86 patients (64%), only 49 (36%) remained ULVACM. IST was started in 41/78 AMI patients (53%), including 9/13 PVs/LPVs+ (69%). Twenty patients (15%) met the study endpoint by 12 months, and 36 (27%) by the end of the study (60±27 months). Beyond malignant VT onset, AMI was the only predictor of events by 12 months (HR 5.0, 95%CI 1.4-18.1, p=0.007). No prognostic role was found for PVs/LPVs, except for the subgroup (n=77) with nonsustained VT onset. Among AMI patients, those treated by IST had a significantly lower occurrence of events, both by 12-months (1/41 vs. 16/37, p<0.001) and later (HR 0.05, 95%CI 0.01-0.21, p<0.001). Results were independently confirmed in PVs/LPVs+ and PVs/LPVs- cases. Excluding the IST population, the association of multiple factors among VT onset, PVs/LPVs, and AMI, resulted in an improved discrimination of arrhythmic risk profiles. Conclusion The combined genetic and histological workup allowed reclassification of up to 64% ULVACM patients, and substantially contributed into prognostic assessment. Furthermore, EMB identified suitable candidates for IST, who showed better outcomes irrespectively of their genotype.
Pulmonary Congestion During Exercise Stress Echocardiography in Ischemic and Heart Failure Patients
Merli, Elisa , Scali, Maria Chiara, Zagatina, A , Merlo, Pablo , Daros, Clarissa Borguezan , Pretto, José Luis de Castro e Silva , Amor, Miguel , Salamè, Michael, Mosto, Hugo , Reisenhofer, Barbara, Wierzbowska‐Drabik, Karina , Kasprzak, Jarosław D. , Ágoston, Gergely , Varga, Albert , Dodi, Claudio , Cortigiani, Lauro , Simova, Iana , Samardjieva, Martina, Citro, Rodolfo , Čelutkienė, Jelena , Re, Federica , Gligorova, Suzana , Antonini‐Canterin, Francesco, Carpeggiani, Clara , Picano, Eugenio , (SIECVI), on behalf of Stress Echo 2020 and 2030 study group of the Italian Society of Echocardiography and Cardiovascular Imaging, Zagatina, Angela , Merlo, Pablo Martin , Borguezan-Daros, Clarissa , de Castro E Silva Pretto, José Luis , Amor, Miguel , Mosto, Hugo , Morrone, Doralisa , Rodriguez-Zanella, Hugo , Kasprzak, Jaroslaw D , Simova, Iana , Citro, Rodolfo , Monte, Ines , Gligorova, Suzana , Pellikka, Patricia A , Wierzbowska-Drabik, Karina , Celutkiene, Jelena , Ciampi, Quirino , Arbucci, Rosina , Morrone, Doralisa , D’Andrea, Antonello , Rodríguez‐Zanella, Hugo , Lowenstein, Jorge , Monte, Ines , Pepi, Mauro , Pellikka, Patricia A. , (SIECVI), on behalf of Stress Echo 2020 and 2030 study group of the Italian Society of Echocardiography and Cardiovascular Imaging

Mayo Clinic

Circulation: Cardiovascular Imaging | May 17, 2022 | Volume: 15 | Issue: 5 | Pages: No page available

10.1161/circimaging.121.013558 | PMID 35580160 Get It

Background: Lung ultrasound detects pulmonary congestion as B-lines at rest, and more frequently, during exercise stress echocardiography (ESE). Methods: We performed ESE plus lung ultrasound (4-site simplified scan) in 4392 subjects referred for semi-supine bike ESE in 24 certified centers in 9 countries. B-line score ranged from 0 (normal) to 40 (severely abnormal). Five different populations were evaluated: control subjects (n=103); chronic coronary syndromes (n=3701); heart failure with reduced ejection fraction (n=395); heart failure with preserved ejection fraction (n=70); ischemic mitral regurgitation ≥ moderate at rest (n=123). In a subset of 2478 patients, follow-up information was available. Results: During ESE, B-lines increased in all study groups except controls. Age, hypertension, abnormal ejection fraction, peak wall motion score index, and abnormal heart rate reserve were associated with B-lines in multivariable regression analysis. Stress B lines (hazard ratio, 2.179 [95% CI, 1.015–4.680]; P =0.046) and ejection fraction <50% (hazard ratio, 2.942 [95% CI, 1.268–6.822]; P =0.012) were independent predictors of all-cause death (n=29 after a median follow-up of 29 months). Conclusions: B-lines identify the pulmonary congestion phenotype at rest, and more frequently, during ESE in ischemic and heart failure patients. Stress B-lines may help to refine risk stratification in these patients. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT 03049995.
Stress Echo 2030: The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging
Pepi, Mauro , Ciampi, Quirino , Cortigiani, Lauro , Arruda‐Olson, Adelaide M. , Daros, Clarissa Borguezan , Pretto, José Luis de Castro e Silva , Bossone, Eduardo , Merli, Elisa , Kane, Garvan C. , Scali, Maria Chiara, Morrone, Doralisa , Simova, Iana , Samardjieva, Martina, Boshchenko, A , Ryabova, T. R. , Pálinkás, Eszter Dalma , Sepp, Róbert , Torres, Marco Antônio Rodrigues , Villarraga, Hector R. , Kovačević-Preradović, Tamara , Citro, Rodolfo , Amor, Miguel , Mosto, Hugo , Salamè, Michael, Leeson, Paul , Gaibazzi, Nicola , Tuttolomondo, Domenico , Prota, Costantina , Peteiro, Jesús , Heyning, Caroline M. Van De , D’Andrea, Antonello , Rigo, Fausto , Ostojić, Miodrag , Arbucci, Rosina , Haber, Diego M. Lowenstein, Merlo, Pablo , Wierzbowska‐Drabik, Karina , Kasprzak, Jarosław D. , Haberka, Maciej , Ratanasit, Nithima , Mori, Fabio , D’Alfonso, Maria Grazia , Tassetti, Luigi , Milazzo, Alessandra , Olivotto, Iacopo , Marchi, Alberto, Rodríguez‐Zanella, Hugo , Zagatina, A , Padang, Ratnasari , Dekleva, Milica , Djordievic-Dikic, Ana, Boskovic, N , Tešić, Milorad , Giga, Vojislav , Salvo, Giovanni Di , Lorenzoni, Valentina , Cameli, Matteo , Bombardini, Tonino, Caso, Pio, Čelutkienė, Jelena , Barbieri, Andréa , Benfari, Giovanni , Bartolacelli, Ylenia , Malagoli, Alessandro , Mantovani, Francesca , Villari, Bruno, Russo, Antonello , Nes, Michele De, Carpeggiani, Clara , Monte, Ines , Re, Federica , Cotrim, Carlos , Bilardo, G, Karužas, Arnas , Matuliauskas, D, Colonna, Paolo , Antonini‐Canterin, Francesco, Pellikka, Patricia A. , (SIECVI), The Stress Echo 2030 Study Group of the Italian Society of Echocardiography and Cardiovascular Imaging, Borguezan-Daros, Clarissa , de Castro E Silva Pretto, José Luis , Bossone, Eduardo , Morrone, Doralisa , Palinkas, Eszter Dalma , Preradović, Tamara Kovačević , Tuttolomondo, Domenico , Peteiro, Jesus , Van De Heyning, Caroline M , D'Andrea, Antonello , Arbucci, Rosina , Wierzbowska-Drabik, Karina , Tassetti, Luigi , Olivotto, Iacopo , Rodriguez-Zanella, Hugo , Tesic, Milorad , Di Salvo, Giovanni , Cameli, Matteo , Mandoli, Giulia Elena , Barbieri, Andrea , Benfari, Giovanni , Bartolacelli, Ylenia , Malagoli, Alessandro , Mantovani, Francesca , Monte, Ines , Cotrim, Carlos , Karuzas, Arnas , Colonna, Paolo , Pepi, Mauro , Pellikka, Patricia A , Ciampi, Quirino , Zagatina, Angela , Kasprzak, Jaroslaw D , Ryabova, Tamara , Gaibazzi, Nicola , Lorenzoni, Valentina , Citro, Rodolfo , Boshchenko, Alla , Celutkiene, Jelena , Cocchia, Rosangela , Varga, Albert , Ágoston, Gergely , Vrublevsky, A. V. , Pálinkás, Attila , Mangia, Cristina , Nikolic, Aleksandra, Lowenstein, Jorge , Camarozano, Ana Cristina , Marchi, Alberto, Beleslin, Branko , Bursi, Francesca , Saad, Ariel K. , (SIECVI), The Stress Echo 2030 Study Group of the Italian Society of Echocardiography and Cardiovascular Imaging

Mayo Clinic

Journal of Clinical Medicine | August 17, 2021 | Volume: 10 | Issue: 16 | Pages: 3641

10.3390/jcm10163641 | PMID 34441937 Get It

With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: the ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021–2025) ≥10,000 patients followed for ≥5 years (up to 2030) from ≥20 quality-controlled laboratories from ≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.
Abstract 18060: Risk Stratification Following Mitral Valve Surgery for Chronic Ischemic Mitral Regurgitation: A Very Long-term Study
Fino, Carlo , Bellavia, Diego , Malouf, Joseph F., Cugola, Diego , Calabrese, Alice, Simon, Caterina, Merlo, Maurizio, Magné, Julien , Miceli, Antonio , Iacovoni, Attilio , D’Elia, Emilia , Caputo, Massimo , Galletti, Lorenzo , Senni, Michele , Traina, Marcello

Mayo Clinic

Circulation | July 3, 2021 | Volume: 132 | Issue: suppl_3 | Pages: No page available

10.1161/circ.132.suppl_3.18060 Get It

Background: Very few long-term data are available on patients undergoing mitral valve surgery for chronic ischemic mitral regurgitation (CIMR). Objective:to identify determinants of survival and adverse cardiovascular events, at very long-term outcome. Methods and Results: We reviewed complete left and right ventricular echocardiographic data, six-minute walking test (6-MWT) and BNP levels at pre, peri and follow-up, on 137 consecutive patients who underwent restrictive mitral annuloplasty (RMA) or mitral valve replacement (MVR) and CABG, for CIMR. Combined adverse cardiovascular events were defined as composite of death, heart failure, angina, myocardial infarction and re-hospitalization. Mean age was 67±0.7. Preoperative EF was 35±06%. Among 137 patients, 46% underwent RMA and 54% had MVR. Median follow- up was 7 years (range: 0.3-15.4). Early mortality was 7% (p=NS). In the RMA 42% of patients experienced MR recurrence. Overall survival at 5, 10 and 15 years were 84, 76 and 62% in RMA, and 87, 62 and 54% in MVR (p=0.65). At univariate analysis, preop B-blocker, 6-MWT, mean transmitral gradients and RV size were predictors of adverse events.The Cox Hazard multivariate analysis identified preoperative atrial fibrillation (p=0.005), preop BNP (p=0.025) as independent predictors of long-term mortality.Freedom from cardiovascular events at 5, 10 and 15 years were 90, 75 and 48% in RMA, and 90, 62 and 45% in MVR (p=0.57). . The Cox Hazard multivariate analysis identified preop B-blocker therapy (p=0.001), atrial fibrillation (p=0.01), postoperative mean transmitral gradients (p=0.047 ) and indexed effective orifice area (p=0.02) as independent predictors of adverse cardiovascular events. Conclusions: Our study confirms an high rate of true MR recurrence, at very long-term follow-up. Among collected variables, preoperative BNP and atrial fibrillation were independent predictors of survival, whereas B-blocker therapy, atrial fibrillation, postoperative mean transmitral gradients and indexed effective orifice area were independent predictors of adverse cardiovascular events. Type of surgery did not affect the very long-term outcome.
Post‐discharge arrhythmic risk stratification of patients with acute myocarditis and life‐threatening ventricular tachyarrhythmias
Gentile, Piero , Merlo, Marco , Peretto, Giovanni , Bella, Paolo Della , Aquaro, Giovanni Donato , Potena, Luciano , Campodonico, Jeness , Foà, Alberto , Hazebroek, Mark R. , Čerček, Andreja Černe , Shrivastava, Sanskriti , Heyning, Caroline M. Van De , Craenenbroeck, Emeline M. Van , Sugimura, Koichiro , Cannatà, Antonio , Porcari, Aldostefano , Colopi, Marzia , Perkan, Andrea, Garascia, Andrea , Pereira, Naveen L. , Heymans, Stéphane , Camici, Paolo G. , Frigerio, Maria , Potena, Luciano , Van De Heyning, Caroline M , Heymans, Stephane , Porcari, Aldostefano , Foà, Alberto , Gentile, Piero , Cannatà, Antonio , Ammirati, Enrico , Sala, Simone , Imazio, Massimo , Raafs, Anne G. , Brambatti, Michela , Nucifora, Gaetano , Huang, Florent , Schmidt, Matthieu , Muser, Daniele , Aoki, Tatsuo , Shimokawa, Hiroaki , Artico, Jessica , Bussani, Rossana , Barbati, Giulia , Cipriani, Manlio , Agostoni, Piergiuseppe , Adler, Eric D , Sinagra, Gianfranco

Mayo Clinic

European Journal of Heart Failure | July 1, 2021 | Volume: 23 | Issue: 12 | Pages: 2045-2054

10.1002/ejhf.2288 | PMID 34196079 Get It

Aims The outcomes of patients presenting with acute myocarditis and life‐threatening ventricular arrhythmias (LT‐VA) are unclear. The aim of this study was to assess the incidence and predictors of recurrent major arrhythmic events (MAEs) after hospital discharge in this patient population. Methods and results We retrospectively analysed 156 patients (median age 44 years; 77% male) discharged with a diagnosis of acute myocarditis and LT‐VA from 16 hospitals worldwide. Diagnosis of myocarditis was based on histology or the combination of increased markers of cardiac injury and cardiac magnetic resonance (CMR) Lake Louise criteria. MAEs were defined as the relapse, after discharge, of sudden cardiac death or successfully defibrillated ventricular fibrillation, or sustained ventricular tachycardia (sVT) requiring implantable cardioverter‐defibrillator therapy or synchronized external cardioversion. Median follow‐up was 23 months [first to third quartile (Q1–Q3) 7–60]. Fifty‐eight (37.2%) patients experienced MAEs after discharge, at a median of 8 months (Q1–Q3 2.5–24.0 months; 60.3% of MAEs within the first year). At multivariable Cox analysis, variables independently associated with MAEs were presentation with sVT [hazard ratio (HR) 2.90, 95% confidence interval (CI) 1.38–6.11]; late gadolinium enhancement involving ≥2 myocardial segments (HR 4.51, 95% CI 2.39–8.53), and absence of positive short‐tau inversion recovery (STIR) (HR 2.59, 95% CI 1.40–4.79) at first CMR. Conclusions Among patients discharged with a diagnosis of myocarditis and LT‐VA, 37.2% had recurrences of MAEs during follow‐up. Initial CMR pattern and sVT at presentation stratify the risk of arrhythmia recurrence.
Hemodynamic Heterogeneity of Reduced Cardiac Reserve Unmasked by Volumetric Exercise Echocardiography
Bombardini, Tonino, Zagatina, A , Ciampi, Quirino , Arbucci, Rosina , Merlo, Pablo , Haber, Diego M. Lowenstein, Morrone, Doralisa , Djordjevic‐Dikic, Ana , Tešić, Milorad , Boskovic, N , Giga, Vojislav , Pretto, José de Castro e Silva, Daros, Clarissa Borguezan , Amor, Miguel , Mosto, Hugo , Salamè, Michael, Citro, Rodolfo , Simova, Iana , Samardjieva, Martina, Wierzbowska‐Drabik, Karina , Kasprzak, Jarosław D. , Gaibazzi, Nicola , Cortigiani, Lauro , Scali, Maria Chiara, Antonini‐Canterin, Francesco, Torres, Marco Antônio Rodrigues , Nes, Michele De, Ostojić, Miodrag , Carpeggiani, Clara , Arruda‐Olson, Adelaide M. , Pellikka, Patricia A. , Imaging, on behalf of the Stress Echo 2020 Study Group of the Italian Society of Cardiovascular, D'Andrea, Antonello , Tesic, Milorad , Amor, Miguel , Monte, Ines , Pellikka, Patricia A , Ciampi, Quirino , Zagatina, Angela , Wierzbowska-Drabik, Karina , Kasprzak, Jaroslaw D , Gaibazzi, Nicola , Morrone, Doralisa , Arbucci, Rosina , Citro, Rodolfo , D’Andrea, Antonello , Beleslin, Branko , Pretto, José Luis de Castro e Silva , Monte, Ines , Pepi, Mauro , Kovačević-Preradović, Tamara , Lowenstein, Jorge , Imaging, on behalf of the Stress Echo 2020 Study Group of the Italian Society of Cardiovascular

Mayo Clinic

Journal of Clinical Medicine | June 29, 2021 | Volume: 10 | Issue: 13 | Pages: 2906

10.3390/jcm10132906 | PMID 34209955 Get It

Background: Two-dimensional volumetric exercise stress echocardiography (ESE) provides an integrated view of left ventricular (LV) preload reserve through end-diastolic volume (EDV) and LV contractile reserve (LVCR) through end-systolic volume (ESV) changes. Purpose: To assess the dependence of cardiac reserve upon LVCR, EDV, and heart rate (HR) during ESE. Methods: We prospectively performed semi-supine bicycle or treadmill ESE in 1344 patients (age 59.8 ± 11.4 years; ejection fraction = 63 ± 8%) referred for known or suspected coronary artery disease. All patients had negative ESE by wall motion criteria. EDV and ESV were measured by biplane Simpson rule with 2-dimensional echocardiography. Cardiac index reserve was identified by peak-rest value. LVCR was the stress-rest ratio of force (systolic blood pressure by cuff sphygmomanometer/ESV, abnormal values ≤2.0). Preload reserve was defined by an increase in EDV. Cardiac index was calculated as stroke volume index * HR (by EKG). HR reserve (stress/rest ratio) <1.85 identified chronotropic incompetence. Results: Of the 1344 patients, 448 were in the lowest tertile of cardiac index reserve with stress. Of them, 303 (67.6%) achieved HR reserve <1.85; 252 (56.3%) had an abnormal LVCR and 341 (76.1%) a reduction of preload reserve, with 446 patients (99.6%) showing ≥1 abnormality. At binary logistic regression analysis, reduced preload reserve (odds ratio [OR]: 5.610; 95% confidence intervals [CI]: 4.025 to 7.821), chronotropic incompetence (OR: 3.923, 95% CI: 2.915 to 5.279), and abnormal LVCR (OR: 1.579; 95% CI: 1.105 to 2.259) were independently associated with lowest tertile of cardiac index reserve at peak stress. Conclusions: Heart rate assessment and volumetric echocardiography during ESE identify the heterogeneity of hemodynamic phenotypes of impaired chronotropic, preload or LVCR underlying a reduced cardiac reserve.
Sensing and Liquid–Liquid Extraction of Dicarboxylates Using Dicopper Cryptates
Cognata, Sonia La , Merlo, Francesca , Recca, Teresa , Maher, L. James , Amendola, Valeria , Maher, Louis J, III, Louis James Maher , Mobili, Riccardo , Speltini, Andrea , Boiocchi, Massimo

Mayo Clinic

ACS Omega | October 7, 2020 | Volume: 5 | Issue: 41 | Pages: 26573-26582

10.1021/acsomega.0c03337 | PMID 33110985 Get It